Vaginal clindamycin and oral metronidazole for bacterial vaginosis: A randomized trial

Obstetrics and Gynecology

Volumn 96, Issue 2, 2000, Pages 256-260

  Paavonen, Jorma ^a   Mangioni, Costantino ^b   Martin, Maureen A ^c   Wajszczuk, Charles P ^c  

^a UNIVERSITY OF HELSINKI   (Finland)

^b SAN GERARDO HOSPITAL   (Italy)

^c PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLINDAMYCIN; METRONIDAZOLE; PLACEBO;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DYSURIA; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; NAUSEA; PRIORITY JOURNAL; PRURITUS; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; VAGINA DISCHARGE; VAGINA DISEASE; VAGINITIS; VOMITING;

ADMINISTRATION, INTRAVAGINAL; ADMINISTRATION, ORAL; ADOLESCENT; ADULT; ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS; CLINDAMYCIN; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; EUROPE; FEMALE; HUMANS; METRONIDAZOLE; MIDDLE AGED; VAGINOSIS, BACTERIAL;

EID: 0033933113     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0029-7844(00)00902-9     Document Type: Article

References (14)

1. Eschenbach D.A., Hillier S., Critchlow C., Stevens C., DeRouen T., Holmes K.K. Diagnosis and clinical manifestations of bacterial vaginosis. Am J Obstet Gynecol. 158:1988;819-828.
2. Mead P.B. Epidemiology of bacterial vaginosis. Am J Obstet Gynecol. 169:1993;446-449.
3. Soper D.E., Bump R.C., Hurt W.G. Bacterial vaginosis and trichomoniasis vaginitis are risk factors for cuff cellulitis after abdominal hysterectomy. Am J Obstet Gynecol. 163:1990;1016-1023.
4. Watts D.H., Krohn M.A., Hillier S.L., Eschenbach D.A. Bacterial vaginosis as a risk factor for postcesarean endometritis. Obstet Gynecol. 75:1990;52-58.
5. Gravett M.G., Nelson P., DeRouen T., Critchlow C., Eschenbach D.A., Holmes K.K. Independent associations of bacterial vaginosis and Chlamydia trachomatis infection with adverse pregnancy outcome. JAMA. 256:1986;1899-1903.
6. Joesoef M.R., Schmid G.P., Hillier S.L. Bacterial vaginosis Review of treatment options and potential clinical indications for therapy . Clin Infect Dis. 28:(suppl 1):1999;S57-S65.
7. 53rd ed. 1999;Medical Economics Co, Montvale, New Jersey.
8. Andres F.J., Parker R., Hosein I., Benrubi G.I. Clindamycin vaginal cream versus oral metronidazole in the treatment of bacterial vaginosis A prospective double-blind clinical trial . South Med J. 85:1992;1077-1080.
9. Schmitt C., Sobel J.D., Meriwether C. Bacterial vaginosis Treatment with clindamycin cream versus oral metronidazole . Obstet Gynecol. 79:1992;1020-1023.
10. Fischbach F., Petersen E.E., Weissenbacher E.R., Martius J., Hosmann J., Mayer H. Efficacy of clindamycin vaginal cream versus oral metronidazole in the treatment of bacterial vaginosis. Obstet Gynecol. 82:1993;405-410.
11. Ahmed-Jushuf I.H., Shahmanesh M., Arya O.P. The treatment of bacterial vaginosis with a 3 day course of 2% clindamycin cream Results of a multicentre, double-blind, placebo controlled trial . B V Investigators Group. Genitourin Med. 71:1995;254-256.
12. Dhar J., Arya O.P., Timmins D.J., Moss S., Mukembo S., Alawattegama A.B., et al. Treatment of bacterial vaginosis with a three day course of 2% clindamycin vaginal cream A pilot study . Genitourin Med. 70:1994;121-123.
13. Swedberg J., Steiner J.F., Deiss F., Steiner S., Driggers D.A. Comparison of single-dose vs one-week course of metronidazole for symptomatic bacterial vaginosis. JAMA. 254:1985;1046-1049.
14. Borin M.T., Powley G.W., Tackwell K.R., Batts D.H. Absorption of clindamycin after intravaginal application of clindamycin phosphate 2% cream. J Antimicrob Chemother. 35:1995;833-841.